Methods for detecting weakly immunogenic analytes

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 7282342
APP PUB NO 20070128660A1
SERIAL NO

11591302

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

GPE antibodies recognize GPE with high specificity. When used in a radioimmunoassay, they reliably measure the concentration of GPE. They may be used to extend the half-life of GPE both in vivo and in vitro, and in methods of purifying the GPE receptor. Two methods of rpHPLC accurately revolve GPE on the basis of its hydrophobicity.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
NEUREN PHARMACEUTICALS LTDLEVEL 3 2-6 PARK AVENUE GRAFTON AUCKLAND
(A) NEURONZ LTDLEVEL 3 2-6 PARK AVENUE GRAFTON AUCKLAND

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Batchelor, David Charles Auckland, NZ 4 4
Heinrich, Breier Bernhard Hermann Auckland, NZ 1 0
Thomas, Gregory Brian Perth, AU 8 44

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation